How much funding has Kolibri raised?

Kolibri has raised $5.0M in total funding, most recently a Grant round.

Who are Kolibri's investors?

Kolibri's investors include Google.org.

Where is Kolibri headquartered?

Kolibri is headquartered in Paris, France.

What industry is Kolibri in?

Kolibri operates in Biotech, Healthcare.

Kolibri

Reimagining cell manufacturing using acoustic waves

Paris, France · Founded 2021 · $5.0M raised

Biotech

Healthcare

Headquarters: Paris
Founded: 2021
Business Model: B2B
Website: kolibrilab.com

Total Funding: $5.0M
Last Round: $5.0M GrantJan 2019
Rounds: 1

About

Kolibri is a Paris-based biotechnology company reimagining cell manufacturing using acoustic waves. The company plays music to cells to unlock the cell culture revolution, applying acoustic cell-manipulation techniques honed over seven years of device development. Kolibri's technology is used to grow and engineer cells at scale for gene therapy and biomanufacturing applications, helping advanced-therapy developers scale production of cell-based treatments.

Summary

Kolibri is a Biotech company based in Paris, France, founded in 2021. It has raised $5.0M in total across 1 round, most recently a $5.0M Grant round in Jan 2019. Investors include Google.org.